participants of group 1mg per kg sugammadex combined with neostigmine 50micrograms per kg were compared with that of 2mg per kg sugammadex group for the main out come of reversal of neuromuscular block in abdominal surgries under general anaesthesia

To compare safety and efficacy of 1mg/kg sugammadex combining with neostigmine 50 g/kg versus 2mg/kg sugammadex for reversal of vecuronium induced shallow neromuscular block in abdominal surgeries under general anaesthesia-A Randomised control study - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091077

Enrollment

Registered

2025-07-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K829- Disease of gallbladder, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: suggamadex 2mg/kg: to compare the time required for reveersal of adequate neuromuscular blockade with suggamadex 2mg/kg observed until 1 hour post surgery Control Intervention1: suggama

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 to 65yr 2. Patient willing to give informed consent. 3. ASA 1-2 4. Patients undergoing elective abdominal surgery under general aneasthesia

Exclusion criteria

Exclusion criteria: 1 Age more than 65years 2 ASA 3 3 patients undergoing emergency surgery 4 patients having allergy to drugs

Design outcomes

Primary

Measure	Time frame
To compare time required for adeqaute reversal of neuromuscular blockade . recovery of the patient observed every 20 seconds for 1 hour post surgeryTimepoint: To compare time required for adeqaute reversal of neuromuscular blockade . recovery of the patient observed every 20 seconds until 1 hour post surgery	—

Secondary

Measure	Time frame
to know the side effectsTimepoint: observed until 1 hour post surgery	—

Countries

India

Contacts

Public ContactDr Yathish S K

Bangalore medical college and research institute Bangalore

skyathish86@gmail.com7338595885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026